Method of preparing photochemotherapic alkylangelicin compounds
US5179217A · kind A · utility
Inventors
Key dates
| Filing date | Dec 27, 1990 |
| Grant date | Jan 12, 1993 |
| Priority date | — |
| Expiry date | Dec 27, 2010 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D311/16
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The alkylangelicins according to the invention are obtained starting from an umbelliferone, in which the 6-position is already substituted by an alkyl group; in such a way the 7-allyloxy or 7-acyloxy umbelliferone intermediates can form by transposition of the allyl or acyl group only the 8-allyl and 8-acyl derivatives, and therefore the presence, even in traces, of psoralens is absolutely excluded in the subsequent synthetic steps. The 6-alkylangelicins thus obtained are particularly usable for the photochemotherapy of psoriasys and of other skin diseases characterized by cellular hyperproliferation, as well as for the photochemotherapy of vitiligo and of alopecia aerata.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.